Global

Research 

Welcome to the KPMG knowledge base of articles and publications that demonstrate our understanding of many of the complex business challenges and key issues faced by companies around the world.
Go Search
Results 1-10 of about 70. Your search took 7.39 seconds.
1  2  3  4  5  Next>  
ImageTitle/DescriptionArticle Date 
 

Issues monitor: pharmaceuticals

Each edition of Issues monitor pulls together and shares our firms' industry-wide knowledge to help you quickly and easily get briefed on issues impacting the pharmaceuticals sector.
Modified date: 10/1/2012
Publication series
 

More than medicine

More than medicine examines strategies and emerging opportunities life sciences companies can use to align their interests and expertise to evolving healthcare systems.
Modified date: 8/22/2014
Business and industry issue; White paper
 

Issues Monitor - Pharmaceuticals

It highlights the benefits & challenges with the adoption of technologies targeted to build efficiency in sales and marketing.
Modified date: 10/1/2012
Business and industry issue
 

Conclusion

Global healthcare systems are evolving to deliver better patient outcomes at lower costs. This shift raises new challenges.
Modified date: 9/18/2014
Business and industry issue; White paper
 

Strategies for success

There are three critical strategies that the life sciences industry must consider in the new healthcare environment.
Modified date: 6/24/2013
Business and industry issue; White paper
 

Healthcare transformation demands new vision and approach from life sciences

The life sciences industry must properly address its most pressing global challenge yet – the rapidly changing healthcare landscape.
Modified date: 6/24/2013
Business and industry issue; White paper
 

The importance of partnering

Several opportunities exist for the life sciences industry to use its talent, scale and data to be a partner to emerging healthcare systems.
Modified date: 6/24/2013
Business and industry issue; White paper
 

What is driving healthcare convergence?

Life sciences companies will increasingly need to work more closely with the healthcare ecosystem to achieve better patient outcomes at lower costs.
Modified date: 6/24/2013
Business and industry issue; White paper
 

Risk and Disclosure in the Global Pharmaceutical Industry

KPMG analysis of Risk and Disclosure in the Global Pharmaceutical and Life Sciences Industry.
Modified date: 7/3/2013
White paper
 

Growing the pipeline, growing the bottom line: Shifts in pharmaceutical R&D innovation

The new report innovation looks at the research challenge through the eyes of senior R&D executives from some of the world’s leading pharma companies.
Modified date: 9/29/2014
White paper
1  2  3  4  5  Next>